Proteomics - Clinical Applications

Aims & Scope

PROTEOMICS - Clinical Applications has developed into a key source of information in the field of applying proteomics to the study of human disease and translation to the clinic.

With 12 issues per year, the journal will publish papers in all relevant areas including: -basic proteomic research designed to further understand the molecular mechanisms underlying dysfunction in human disease -the results of proteomic studies dedicated to the discovery and validation of diagnostic and prognostic disease biomarkers -the use of proteomics for the discovery of novel drug targets -the application of proteomics in the drug development pipeline -the use of proteomics as a component of clinical trials.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	2.10

SJR (SCImago Journal Rank)

Year	Value
2024	0.671

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	67

Journal Rank

Year	Value
2024	8540

Journal Citation Indicator

Year	Value
2024	245

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Exosomes in bodily fluids are a highly stable resource of disease biomarkers

  Citation: 493

  Authors: Stephanie, Suresh

• Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons?

  Citation: 428

  Authors: Eva‐Maria, Niko, Stefan, Christine, Wiebke, Hendrik, Klaus‐Armin, Hansjörg, Jacqueline

• Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

  Citation: 410

  Authors: Elizabeth J., Fiona M., Stefan, Oliver, Mark D.

• ELISA in the multiplex era: Potentials and pitfalls

  Citation: 347

  Authors: Patrick J., Richard R., Ian, Lucy C.

• Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics

  Citation: 332

  Authors: Eric W., Luis, David, Joseph, Zhi, Robert L.

• Cathepsin B: Multiple roles in cancer

  Citation: 320

  Authors: Neha, Bonnie F.

• Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders

  Citation: 281

  Authors: Stefan, Sonja, Henrike

• Clinical proteomics: A need to define the field and to begin to set adequate standards

  Citation: 257

  Authors: Harald, Rolf, Rosamonde E., Mark, Joshua, Anna, Jochen H. H., Danilo, Mark, Henning, Denis, Joachim, Bruce A., Walter, Ziad A., Christian, Jan, Karlheinz, Kasper, Joost, O. John, Dan, Visith, Eva M., Jennifer E., Tadashi

• Aptamers and the next generation of diagnostic reagents

  Citation: 224

  Authors: Varatharasa, David G.

• The pig as an animal model for human pathologies: A proteomics perspective

  Citation: 222

  Authors: Anna, Cristina, P. David, Jesús, Josefa, Joan

---